How Enterovirus A71 Reaches the Brain: A Multistage Model of Neuroinvasion

Enterovirus A71, a virus best known for causing hand, foot, and mouth disease in children, occasionally produces severe neurological complications, yet most infections remain confined to peripheral sites. A new review article in Frontiers in Microbiology argues that this striking disparity can only be understood by treating EV-A71 neuropathogenesis as a multistage process rather than a single event. The authors, led by YZ Yi Zhang of Zunyi Medical University, propose that progression to severe disease requires the virus to overcome distinct constraints at each successive stage, from peripheral replication through systemic dissemination, central nervous system entry, establishment of productive CNS infection, and ultimately tissue injury.

The review emphasizes that these stages are mechanistically connected but not interchangeable. Crossing the blood-brain barrier, for example, is not synonymous with disrupting it, and gaining entry to the central nervous system does not necessarily lead to productive infection there.

According to the authors, current evidence supports two routes of CNS entry: a neurovascular route across the blood-brain barrier and a peripheral neural route along nerves. The strength of the supporting evidence, however, differs markedly between the two. Human-derived blood-brain barrier models demonstrate that EV-A71 and virus-associated carriers can engage and cross neurovascular interfaces, establishing mechanistic feasibility for the vascular route.

For the peripheral neural route, the evidence base is described as more causally robust. Temporal studies in animals, perturbation of axonal transport, and compartmentalized neuronal models together provide stronger causal support for retrograde axonal transport, the process by which the virus travels backward along nerve fibers toward the central nervous system once it has accessed peripheral nerves.

Despite this mechanistic progress, the review is explicit about what remains unknown. The timing, necessity, and relative contribution of each route during natural infection in children remain unresolved. Animal models and in vitro systems can demonstrate what is possible, but they cannot by themselves establish what actually happens in the course of human infection, where the interplay of viral properties, host factors, and tissue context may differ substantially.

To organize these observations, the authors propose a multistage progression-constraint model. In this framework, progression to severe neurological disease requires EV-A71 to overcome distinct barriers imposed by tissue context, viral properties, and host factors at successive stages. Most infections fail at one of these constraints and remain peripheral, while only a minority of viruses successfully navigate every stage and produce CNS disease. The model is presented as a testable explanation rather than a settled conclusion, and it generates specific questions about where in the sequence most infections are stopped.

The framework also highlights the need for longitudinal clinical studies that follow infected children over time, as well as directly comparable experimental models that allow findings from different laboratories to be aligned. Without such comparability, the authors suggest, the field will struggle to identify the precise point at which disease trajectories diverge, which is arguably the most clinically important question in EV-A71 neuropathogenesis.

The review was received on 1 September 2026 and accepted on 12 October 2026, and its final formatted version is pending publication. It was authored by researchers at Zunyi Medical University, its affiliated hospital, and Zunyi Medical and Pharmaceutical College, with correspondence attributed to Bo Huang and Zhenzhuang Zou.

For clinicians and researchers, the central message is one of caution and structure. EV-A71 remains an important cause of severe neurological complications of hand, foot, and mouth disease in children, and understanding why only a small proportion of infections progress to CNS disease requires disentangling entry, establishment, and injury as separate events. The multistage constraint model offers a roadmap for that effort, while the authors themselves stress that the mechanisms underlying the transition from peripheral infection to neurological disease remain incompletely understood and demand further study.

Subject of Research: Mechanisms of Enterovirus A71 neuroinvasion, including blood-brain barrier crossing and retrograde axonal transport

Article Title: Enterovirus A71 neuroinvasion: central nervous system entry, blood–brain barrier dynamics, and multistage constraints

Article References: Zhang, Y., Li, Z., Gu, Y., Huang, B., & Zou, Z. (2026). Enterovirus A71 neuroinvasion: central nervous system entry, blood–brain barrier dynamics, and multistage constraints. Frontiers in Microbiology, 17, 1984969. https://doi.org/10.3389/fmicb.2026.1984969

Image Credits: AI Generated

DOI: 10.3389/fmicb.2026.1984969

Keywords: Enterovirus A71, neuroinvasion, blood-brain barrier, retrograde axonal transport, hand, foot, and mouth disease, central nervous system, virology, neuropathogenesis, systemic dissemination, children, review article, Enterovirus